5-HT2A receptor drugs for Treatment-Resistant Depression

2 tracked 5-HT2A receptor drugs in the Treatment-Resistant Depression race. The class explanation lives on the 5-HT2A receptor page; the full indication pipeline across every mechanism is on the Treatment-Resistant Depression page.

2 Phase 2

Head-to-head evidence: BPL-003 (mebufotenin benzoate) vs VLS-01

The roster

← all 5-HT2A receptor drugs